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ABSTRACT
Introduction: Internet-delivered psychological
interventions among people with chronic pain have the
potential to overcome environmental and economic
barriers to the provision of evidence-based
psychological treatment in the Irish health service
context. While the use of internet-delivered cognitive–
behavioural therapy programmes has been consistently
shown to have small-to-moderate effects in the
management of chronic pain, there is a paucity in the
research regarding the effectiveness of an internet-
delivered Acceptance and Commitment Therapy (ACT)
programme among people with chronic pain. The
current study will compare the clinical-effectiveness
and cost-effectiveness of an online ACT intervention
with a waitlist control condition in terms of the
management of pain-related functional interference
among people with chronic pain.
Methods and analysis: Participants with non-
malignant pain that persists for at least 3 months will
be randomised to one of two study conditions. The
experimental group will undergo an eight-session
internet-delivered ACT programme over an 8-week
period. The control group will be a waiting list group
and will be offered the ACT intervention after the 3-
month follow-up period. Participants will be assessed
preintervention, postintervention and at a 3-month
follow-up. The primary outcome will be pain-related
functional interference. Secondary outcomes will
include: pain intensity, depression, global impression
of change, acceptance of chronic pain and quality of
life. A qualitative evaluation of the perspectives of the
participants regarding the ACT intervention will be
completed after the trial.
Ethics and dissemination: The study will be
performed in agreement with the Declaration of
Helsinki and is approved by the National University of
Ireland Galway Research Ethics Committee (12/05/05).
The results of the trial will be published according to
the CONSORT statement and will be presented at
conferences and reported in peer-reviewed journals.
Trial registration number: ISRCTN18166896.
INTRODUCTION
Chronic pain is a common condition that
affects between one in three1 and one in six
adults.2 It is a major public health problem
that often runs a relapsing and recurrent
course and is defined as an unpleasant
sensory and emotional experience associated
with actual or potential tissue damage, or
described by the patient in terms of such
damage which persists for a period in excess
of 3 months.3 While chronic pain can be
associated with a number of progressive or
degenerative conditions, it most commonly
occurs in people with benign medical condi-
tions such as musculoskeletal problems. For
many people, the presence of chronic pain
has adverse effects on their daily functioning,
employment, relationships and emotional
functioning.1 2 Considering its associated
direct and indirect expenditures, chronic
pain is also a costly social phenomenon.1 2 4
A recent estimate of the cost of chronic pain
in Ireland was €5.34 million, or 2.86% of the
gross domestic product per year.5
Cognitive–behavioural therapy (CBT) is the
standard psychological treatment for people
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with chronic pain6–11 and it underpins many of the inter-
disciplinary pain management programmes. However, it is
apparent that some people who experience chronic pain
do not benefit from CBT interventions.11–14 Therefore,
clinicians and researchers continue to examine alternative
forms of psychological treatment for this large clinical
population. The primary aim of CBT is to control and
minimise pain-related distress; however, in recent years,
there has been a shift towards strategies that promote the
acceptance of pain. The Acceptance and Commitment
Therapy (ACT)15 treatment model consists of awareness
and non-judgemental acceptance of all experiences, both
positive and negative; identification of valued life direc-
tions and appropriate action towards goals that support
those values.15 16 The aim of ACT is to increase function-
ing and decrease interference of pain with value-driven
action.16 The empirical support for ACT has increased
considerably in recent years. Until now, there are at least
eight randomised controlled trials in support of the effi-
cacy of ACT programmes in the management of chronic
pain.16–23 A wide array of methods of programme delivery
have been evaluated, including variations of duration of
treatment sessions, method of delivery of ACT sessions
(group, one-to-one, internet-delivered or self-help) and
length of ACT intervention (ranging from 4 to 10 ses-
sions). The results of a systematic review and meta-analysis
of the literature demonstrated that acceptance-based ther-
apies have small but consistent effects on physical and
mental health among people with chronic pain (standar-
dised mean differences (SMD’s) 0.37 to 0.41),11 which are
comparable to those of CBT (SMD’s −0.15 to −0.21).9
Traditional multidimensional rehabilitation for
people with chronic pain requires expensive specia-
lised clinics.19 24 Access to ACT treatment programmes
and other psychological treatment programmes is
often limited due to various individual and systemic
barriers including direct and indirect costs, mobility
limitations, long waiting lists and insufficient numbers
of appropriately trained health professionals.24 25 One
approach that aims to increase access to psychological
intervention which has received increased attention in
recent years is internet-delivered psychological
therapy.22 24 26–30 Such internet-delivered programmes
provide standardised evidence-based psychological
treatment at minimal cost and interference for people
with chronic pain.19 31 Recently, one randomised con-
trolled trial has examined the clinical-effectiveness of
a guided internet-based ACT intervention among 76
people with chronic pain.22 The results demonstrated
that participants who received the ACT intervention
demonstrated significant improvements regarding
activity engagement and willingness to experience pain
symptoms at both postintervention and at 6-month
follow-up, compared with people who partook in a
moderated online discussion forum. Furthermore, the
authors called for future investigation of the costs and
cost-savings of an online ACT intervention for people
with chronic pain.
The significant cost of chronic pain internationally1
and in Ireland4 5 provides a clear rationale for the
current study to focus on the economic evaluation of an
internet-delivered ACT intervention. A thorough under-
standing of the economic cost of chronic pain is crucial
to inform decision-making regarding health service
resource allocation, especially for high-intensity service
users.4 This aspect of the study will be conducted with a
view to giving more affordable alternative options to the
current chronic pain management services in Ireland.
Given the limited number of randomised controlled
trials of ACT interventions for chronic pain and specific-
ally internet-guided ACT interventions, the present study
aims to examine the clinical-effectiveness and cost-
effectiveness of an internet-delivered ACT treatment pro-
gramme among a sample of people with chronic pain. It
is hypothesised that people in the ACT treatment group
will report significant improvements on measures of
pain intensity, physical functioning, emotional function-
ing and rating of overall improvement, relative to a wait-
list control group.
METHODS AND ANALYSIS
Design
The design is a single-blind randomised controlled trial
comparing the effect of an internet-delivered ACT inter-
vention with a waiting list control condition in the man-
agement of chronic pain. Any modifications to the
protocol which may impact on the conduct of the study
will require a formal amendment to the protocol. Such
amendment will be agreed on by the Irish Health
Research Board Interdisciplinary Capacity Enhancement
Award, grant number (ICE/2011/19) research group,
and approved by the relevant ethics committee prior to
the implementation of the modifications. Minor admin-
istrative changes to the protocol will be agreed on by the
Irish Health Research Board Interdisciplinary Capacity
Enhancement Award, grant number (ICE/2011/19)
research group, and will be documented in a
memorandum.
Recruitment, participants and randomisation
Recruitment of the participants will be conducted via
advertisements about the trial on websites which offer
information and services to people with chronic pain and
via advertisements in local general practitioner and physio-
therapy clinics. People who are interested in taking part in
the trial will be invited to contact the Centre for Pain
Research via phone or email, wherein they will be given an
opportunity to ask questions about the trial. When con-
tacted, the researcher will explain the study in detail.
Interested people will be directed to the trial website where
they will be encouraged to read additional information
about the trial (see online supplementary appendix 1) and
apply to participate. Selection criteria are: aged 18 years or
more, the presence of pain for at least 3 months duration,
resident of Ireland, regular access to a computer and to the
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internet, not currently undergoing any other form of psy-
chological intervention for chronic pain, not currently
experiencing a psychotic illness (screened with a Health
Problems Questionnaire),32 not experiencing chronic pain
due to malignancy and adequate English language ability.
Participation in any other form of psychological interven-
tion for chronic pain in addition to the study intervention
is prohibited during the trial. All participants will provide
full informed consent. Participants will be randomised to
the intervention or waiting list control group using random
permuted blocks to ensure that the groups are balanced
periodically. The randomisation process will be performed
by a web-based password secured and encrypted data man-
agement system designed specifically for the randomisation
of participants into clinical trials. Once the randomisation
procedure has been completed, the participants in the
online ACT intervention group will begin the intervention.
The statistician involved in the analysis of the data will be
blinded to group allocation. As the study involves a psycho-
logical intervention with a waitlist control group, blinding
of the participants will not be possible.
TREATMENT REGIMENS
The internet-delivered ACT intervention will consist of
eight sessions over an 8-week period and is based on an
unpublished manual used in a previous study of people
with chronic pain.33 Other relevant resources and
literature were also used in designing the online ACT
programme.15 34 35 The programme will be delivered via
the interactive online platform Lifeguide (http://www.
lifeguideonline.org/). It will consist of information,
homework assignments, relevant ACT metaphors and
mindfulness exercises. This treatment protocol is
focused on the promotion of acceptance, present-
focused awareness and engagement in value-based
action. Detailed information about the content of the
treatment programme is outlined in table 1. The
current ACT intervention has been developed into an
online format by a postdoctoral clinical psychologist who
has experience in psychological and behavioural treat-
ment of chronic pain (HD) and a postdoctoral physio-
therapist (SH) under the supervision of a licensed
clinical psychologist specialising in pain management
(BM) and a psychologist with expertise in the ACT
approach (MH). In addition, qualitative one-to-one
interviews will be conducted with an opportunistic
sample of individuals with chronic pain to explore their
perception of the main problems posed by chronic pain
to functioning and participation in important areas of
their lives. Following content analysis, the insights
gained from the qualitative data will be incorporated
into the ACT intervention. Each of the sessions will be
subjected to as many reviews as necessary, by both the
research team and individuals with chronic pain, to
ensure that both interface and content are understand-
able, engaging and have the potential to achieve the aim
of the internet-delivered ACT intervention, that is,
increase functioning and decrease interference of pain
with value-driven action. To maximise participant
engagement and experiential learning, all aspects of this
programme will include audio and visual presentations.
Each lesson will begin with a summary of previous
lessons and an introduction to the contents of the
current lesson. Summaries of key points will be outlined
in each lesson, and concepts and skills described in
earlier lessons will be repeated and combined in later
lessons. Weekly emails will be sent to participants,
wherein they will be notified of new content and
reminded about the course material that they have not
accessed.24 Participants will also receive weekly phone
calls from a member of the research team throughout
the duration of the intervention. The phone calls will be
structured and will aim not only to motivate and encour-
age the participants but also to give them the opportun-
ity to ask questions about the intervention. However, the
phone calls are not intended to form part of the therapy
per se. Adherence to the trial intervention will be moni-
tored automatically via the online delivery platform
(Lifeguide) and adherence to the trial assessments will
be monitored automatically via the online survey pro-
vider. If a participant wishes to discontinue their
assigned intervention, access to the intervention will be
withdrawn from the participant and this will be reported
as attrition. However, in an attempt to enable follow-up
data collection and prevent missing data, the study par-
ticipant will be retained in the trial whenever possible.
Participants allocated to the waitlist control condition
will not receive the internet-delivered ACT intervention
at that time. They will be contacted by the postdoctoral
researcher to explain that they have been allocated to
the waiting list control group, at which time they will be
given an opportunity to ask questions regarding the
trial. All participants, including the waitlist control
group, will be offered the opportunity to utilise the
online ACT intervention after the 3-month follow-up
assessment.
OUTCOME MEASURES
All outcome measures are self-reported and will be
conducted during the week immediately preinterven-
tion, during the week immediately postintervention
and at a 3-month follow-up. Participants will receive
instructions on how to complete each self-report
measure according to standardised instructions for
each measure of outcome. The outcome measures
chosen for inclusion in this trial are based on the
Initiative on Methods, Measurement, and Pain
Assessment in Clinical Trials (IMMPACT) recommen-
dations for outcome measures for chronic pain clinical
trials.12 The four core chronic pain outcome domains
will be measured, namely: pain intensity, physical func-
tioning, emotional functioning and participants’ rating
of overall improvement. Any adverse events and the
rate of attrition among the participants during their
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completion of the intervention will also be recorded.
Additional measures of potential confounding vari-
ables will be included to allow for the accounting of
these variables in the analyses.
Demographic and clinical information
Participants will be asked to supply details regarding age,
gender, highest educational attainment, occupational
status and relationship status as well as duration of
chronic pain, site(s) of chronic pain and cause of
chronic pain. Some details about previous and current
medical and alternative treatment will also be collected.
Primary outcome measure
Brief pain inventory-short form
The Brief pain inventory-short form36 measures pain
severity and the degree of interference with function,
using a numerical rating scale from 0 to 10. The inter-
ference scale is a seven-item self-report measure,
designed to assess the extent to which pain interferes
with various components of functioning, including phys-
ical and emotional functioning and sleep. The items in
this scale can be grouped into those that assess physical
functioning (general activity, walking ability, normal
work, including work outside the home and housework),
those that assess emotional functioning (mood, relations
with people, enjoyment of life) and a single item that
Table 1 Overview of the internet-delivered Acceptance and Commitment Therapy (ACT) intervention programme
Week Session Summary of content
1 Session 1 ▸ Introduction to the ACT programme and programme overview
▸ Review treatment history and evaluate it in terms of how it has worked relative to the participant’s
goals and expectations
▸ Review interactions between thoughts, feelings and function, which often serve to make each other
worse (eg, become a ‘vicious cycle’)
▸ Introduce the idea that change is possible—not based on symptom reduction but on aiming to alter
function
▸ Introduction to mindfulness technique—which is followed by the mindfulness debrief regarding the
participants’ experiences of mindfulness
2 Session 2 ▸ Introduction to the concept of acceptance and how one’s experience of pain may limit participation
in valued activities
▸ Values clarification exercises
▸ Mindfulness and debrief
▸ Homework assignment: mindfulness practice daily
3 Session 3 ▸ Identification of values
▸ Assessment and rating of values
▸ Discrepancy between values and current function
▸ Mindfulness of breath exercise
▸ Mindfulness debrief
▸ Homework assignment: mindfulness practice daily
4 Session 4 ▸ Barriers to pursuing values
▸ Overcoming barriers
▸ Swamp metaphor—exercise exploring the possibility for value-based action even with aversive
experiences. Discussion on the concept of willingness and unwillingness to have discomfort
▸ Body scan mindfulness exercise
5 Session 5 ▸ Goal setting exercise in line with three chosen values
▸ Discussion on fluctuating levels of high and low functioning and benefits of activity pacing in order to
achieve a more consistent level of activity from day to day.
▸ Homework assignment: record performance over the next week regarding carrying out specific
actions and pacing of activities
6 Session 6 ▸ ‘Tricks of the mind’ exercises to raise awareness of language-based influences on function
▸ Cognitive defusion exercises—‘catch’ your thoughts and label them
▸ Homework assignment: practice mindfulness and cognitive defusion techniques daily
7 Session 7 ▸ Planning and action
▸ ‘Act On’=Taking the ‘I’ out of action
▸ Homework assignment: commit yourself to action
8 Session 8 ▸ End of programme
▸ Emphasis on commitment to actions and values even when barriers exist and future planning—this
is a ‘lifelong assignment’
▸ Preparation for relapses and setbacks
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assesses the extent to which pain interferes with sleep.
Tan et al37 reported acceptable internal consistency for
the interference scale (Cronbach’s α, α=0.88). Excellent
test–retest reliability of the BPI has also been demon-
strated among people with chronic pain due to osteo-
arthritis.38 Correlation coefficients ranging from r=0.83–
0.88 and from r=0.83–0.93 were reported for the pain
intensity and for the pain interference scales, respect-
ively.38 Reductions in pain intensity between 10% and
20% represent a minimal clinically meaningful change
and a reduction of one point on the interference scale
has been recommended as a clinically meaningful
change among people with chronic pain.39
Secondary outcome measures
Beck depression inventory
The Beck Depression Inventory (BDI)40 41 consists of 21
groups of four statements designed to assess the severity
of current symptoms of depressive disorders, with total
scores on the measure ranging from 0 to 63. Previous lit-
erature demonstrates acceptable internal consistency
(Cronbach’s α 0.73–0.95), test–retest reliability (r 0.80–
0.90), convergent validity (mean r=0.60) and responsive-
ness to change of the BDI.39 42
Pain Anxiety Symptoms Scale-20
The Pain Anxiety Symptoms Scale-20 (PASS-20)43 is a
20-item scale which measures pain-specific anxiety symp-
toms and consists of four five-item subscales measuring
cognitive anxiety responses, escape and avoidance,
fearful thinking and physiological anxiety responses. All
items are measured on a frequency scale ranging from 0
(never) to 5 (always).44 Psychometric evaluation of the
PASS-20 demonstrated that this scale has strong internal
consistency (Cronbach’s α 0.75–0.91) and convergent
validity (mean r 0.95) and adequate construct validity (r
0.24–0.69).44
Patient Global Impression of Change
The Patient Global Impression of Change (PGIC)
scale45 was recommended by IMMPACT for use in
chronic pain clinical trials as a core outcome measure of
global improvement with treatment.39 This single-item
rating by participants of their response during clinical
trials uses a seven-point rating scale with the options
‘very much improved’, ‘much improved’, ‘minimally
improved’, ‘no change’, ‘minimally worse’, ‘much worse’
and ‘very much worse’. The percentages of the partici-
pants endorsing each of the seven response options in
each group will be analysed and reported separately.
Chronic Pain Acceptance Questionnaire-8
The Chronic Pain Acceptance Questionnaire-8
(CPAQ-8)46 is a short version of the CPAQ47 and consists
of eight items which measure activity engagement and
pain willingness, which reflect the central tenets of ACT.
Each item is scored on a Likert scale ranging from 0,
‘never true’, to 6, ‘always true’, and higher scores
indicate greater activity engagement and pain willing-
ness. The internal consistency and the test–retest reli-
ability of the CPAQ are well established (Cronbach’s α
0.72–0.92 and interclass correlation coefficient=0.86;
95%CI 0.81 to 0.90), respectively.48–51 Recent confirma-
tory factor analyses provide further support for the two-
factor structure of the original scale.52 53 In addition,
the CPAQ-8 has been validated in samples of people
with chronic pain.46 51 54 55
EQ-5D
EQ-5D is a standardised instrument for use as a measure
of health-related quality of life (HRQOL) outcome.
Applicable to a wide range of health conditions and
treatments, it provides a simple descriptive profile and a
single index value for health status. The EQ-5D descrip-
tive system will be included which asks respondents to
assess their mobility, self-care, usual activities, pain/dis-
comfort and anxiety and depression on a five-point
scale: no problems, slight problems, moderate problems,
severe problems and extreme problems. The EQ Visual
Analogue Scale (EQ VAS) will also be included which
records the respondent’s self-rated health on a vertical
VAS where the end points are labelled ‘best imaginable
health state’ and ‘worst imaginable health state’. The
EQ-5D has been shown to have good construct validity
and responsiveness among people with chronic pain.56
Client Service Receipt Inventory
Medication and health service use will be measured at
baseline, post-treatment and follow-up, using the pain
version of the Client Service Receipt Inventory (CSRI).57
The CSRI has been widely used in research to examine
the cost of chronic pain,5 58–60 and has been shown to
be a valid measure of frequency of health service use.61
Medication use is likely to vary throughout the trial dur-
ation. As a result, change in medication use (including
prescribed and over-the-counter medications) will be
measured in post-treatment analysis.
Statistical analysis
A sample size of 63 per group (total=126) will have 80%
power, at the 5% significance level, to detect a minimum
clinically significant difference in mean improvement on
the interference scale score of the BPI of 1 unit (SD of
improvement of 2 units) compared to the controls based
on a two-sample t test. These estimates were derived from
the IMMPACT consensus statement regarding the
minimum clinically significant change.39 A recent
internet-delivered ACT intervention, similar in design
and content of the current proposed intervention,
demonstrated 20% attrition between allocation and
6-month follow-up.22 Therefore, in line with this antici-
pated rate of attrition, 152 people with chronic pain will
be recruited. The study will be analysed using the princi-
ples of intention-to-treat analysis. Suitable graphical (eg,
box plots, labelled scatter-plots and case profile plots)
and numerical summaries (means, medians, SDs and
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quartiles) will be provided for all variables at baseline and
for corresponding change scores. As the primary
outcome measure, BPI, is measured on an 11-point scale,
it will be treated as a continuous variable. The change in
the primary response over time (baseline vs postinterven-
tion vs 3-month follow-up) will be analysed using a linear
mixed model adjusting for baseline, treatment group and
within-subject correlation while further adjusting for
demographic and clinical explanatory variables as neces-
sary. Model selection will be based on the Akaike
Information Criterion62 and the underlying assumption
through suitable plots of the residuals. A similar
approach will be used when analysing the change in
those secondary outcome measures recorded on a con-
tinuous scale while a non-linear mixed model will be
used to compare the changes in the proportions of the
ordinal PGIC variable. The sensitivity of the final results
to missing data will be investigated using multiple imput-
ation analysis based on chained equations and predictive
mean matching.63 All analyses will be completed using a
combination of Minitab 16, IBM SPSS V.20 and R (3.02)
statistics packages. Each hypothesis will be tested using a
two-tailed analysis at the α=0.05 level of significance.
Qualitative evaluation
Qualitative evaluation of the internet-delivered ACT pro-
gramme will be achieved by inviting participants who
have completed the intervention to take part in
Participative Research Process (PRP)64 65 workshops to
explore their views on the effectiveness and acceptability
of the intervention. The PRP facilitates participants to
generate, collate and present their ideas, based on their
experience of the internet-delivered ACT intervention.
During the PRP workshops, participants will discuss the
different elements of the online ACT intervention and
explore, through the creation of a Web of Ideas,66 if and
how the intervention was an effective way to improve the
lives of people with chronic pain.
Economic evaluation
An incremental cost-effectiveness analysis will be con-
ducted to compare the costs and outcomes of the ACT
intervention compared to the control group. Health bene-
fits will be assessed using the disease-specific clinical effect-
iveness health measures. Cost-utility analysis will also be
conducted using the EQ-5D to assess improvements in
HRQOL. In terms of estimating costs, we will include costs
falling on the health and social care sector including medi-
cation use using data collected as part of the CSRI. Once
we have information on the quantity of use, we will trans-
late these into costs using unit cost data available for
Ireland for each of the services/products. In the case of
hospital costs, resource use will be recorded using
diagnosis-related group unit costs. Primary healthcare
costs will be calculated using medical card capitation rates
and the average charge for non-medical card holders.56
We will also record non-medical costs related to
out-of-pocket expenses incurred by the person with
chronic pain and their family. These will include expend-
iture on any treatment not paid by the state, the costs of
travelling to, and wait times at, the various healthcare ser-
vices. We will also record the opportunity cost of work by
gathering information on the costs associated with taking
time off work or reduced employment for the person with
chronic pain or for family members who care for the
person with chronic pain. To determine these costs, infor-
mation on wages will be collected where possible to value
these costs. If this is not available, other information such
as income, marital status, age and education will be used
to provide a proxy for the wage. Uncertainty in the analysis
will be explored using a combination of univariate and
multivariate analyses, and decision uncertainty will be
addressed using cost-effectiveness acceptability curves.56
DATA MONITORING AND MANAGEMENT
This trial does not have a data and monitoring commit-
tee for the following reasons: the study is minimal risk,
chronic pain is a non-life-threatening condition, and the
nature of the study population (adult, not considered
vulnerable).
All study-related information will be stored securely at
the study site. All participant information will be stored in
locked file cabinets in areas with limited access, or on
encrypted electronic devices, as appropriate. All records
that contain names or other personal identifiers will be
stored separately from study records identified by code
number. All local and online databases will be secured
with password-protected access systems. Paper-based docu-
ments that link participant ID numbers to other identify-
ing information will be stored in a separate locked file in
an area with limited access. Data stored on computer data-
bases will be password-protected and access to files will be
limited to research staff who require direct access. The
trial statistician will work on depersonalised data where the
participant’s identifying information will be replaced by an
unrelated sequence of characters. All principal investiga-
tors and post-doctoral researchers involved in the running
of the trial will be given access to the cleaned data sets. All
data sets will be password protected. To ensure confidenti-
ality, data dispersed to project team members will be
blinded of any identifying participant information.
DISSEMINATION
Regardless of the significance, direction or magnitude
of effect, the trial findings will be submitted for publica-
tion in peer-reviewed journals. Trial findings will also be
disseminated through conference abstracts. Once all of
the data have been collected and cleaned, we will aim to
submit the trial results for publication within 3 months.
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